CEDRUS’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $386K | Buy |
624
+152
| +32% | +$94K | 0.14% | 119 |
|
|
2024
Q2 | $261K | Sell |
472
-43
| -8% | -$23.8K | 0.13% | 135 |
|
|
2024
Q1 | $299K | Sell |
515
-29
| -5% | -$16.9K | 0.16% | 118 |
|
|
2023
Q4 | $289K | Sell |
544
-35
| -6% | -$18.6K | 0.18% | 122 |
|
|
2023
Q3 | $293K | Sell |
579
-106
| -15% | -$53.7K | 0.21% | 110 |
|
|
2023
Q2 | $357K | Sell |
685
-16
| -2% | -$8.35K | 0.25% | 89 |
|
|
2023
Q1 | $404K | Sell |
701
-19
| -3% | -$11K | 0.28% | 74 |
|
|
2022
Q4 | $396K | Sell |
720
-14
| -2% | -$7.71K | 0.32% | 67 |
|
|
2022
Q3 | $372K | Buy |
734
+56
| +8% | +$28.4K | 0.35% | 56 |
|
|
2022
Q2 | $368K | Buy |
678
+26
| +4% | +$14.1K | 0.36% | 54 |
|
|
2022
Q1 | $385K | Buy |
652
+77
| +13% | +$45.5K | 0.35% | 68 |
|
|
2021
Q4 | $384K | Buy |
+575
| New | +$384K | 0.37% | 80 |
|